NCT02406989View on ClinicalTrials.gov

A Multiple-Ascending Dose Study of MS-553 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Safety and PK in Healthy Volunteers
Interventions
DRUG

MS-553

Study Drug

DRUG

Placebo

Matching placebo to MS-553

Trial Locations (1)

3122

Nucleus Network, Melbourne

Sponsors
All Listed Sponsors
lead

MingSight Pharmaceuticals Pty Limited

INDUSTRY

NCT02406989 - A Multiple-Ascending Dose Study of MS-553 in Healthy Volunteers | Biotech Hunter | Biotech Hunter